肠溶软胶囊市场规模、份额及成长分析（依产品类型、原料、通路、应用、最终用户及地区）－2025-2032 年产业预测

2023 年全球肠溶软胶囊市场规模为 24 亿美元，预计将从 2024 年的 25 亿美元成长到 2032 年的 34.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.1%。

肠溶软胶囊市场预计将显着增长，因为消费者对预防医学益处的认识不断提高、老年人口不断增长以及慢性病和营养不良的流行。肠溶软胶囊是一种用于半固态和液体药物的明胶包衣软胶囊。随着人们健康意识的增强，膳食补充剂也越来越受到认可，进一步推动了需求。值得注意的是，创新的非明胶产品正在涌现，以满足素食消费者的需求，利用淀粉和植物来源成分来增加市场吸引力。此外，电子商务平台的扩张和领先公司为提高胶囊的生物利用度而活性化的研发投入可能会对市场动态正面影响。可咀嚼软胶囊不需用水服用，预计未来几年将提升市场前景。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

肠溶软胶囊市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 明胶软胶囊
• 素食软胶囊

肠溶软胶囊市场规模（按原料及复合年增长率） (2025-2032)

• 市场概览
• A型明胶（猪皮）
• B型明胶（动物骨骼和皮肤）
• 鱼骨明胶
• 纤维素衍生物
• 淀粉类物质

肠溶软胶囊市场规模（依分销管道划分）及复合年增长率（2025-2032）

• 市场概览
• 超级市场和大卖场
• 药局和药局
• 线上提供者

肠溶软胶囊市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 制酸剂和肠道调节剂
• 抗发炎药物
• 抗生素和抗菌剂
• 咳嗽和感冒药
• 健康补充品
• 维生素和营养补充剂
• 其他治疗用途

肠溶软胶囊市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 製药公司
• 营养补充品公司
• 化妆品公司
• 食品工业

肠溶软胶囊市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• BASF SE（Germany）
• Colorcon Inc.（United States）
• Fuji Capsule Co., Ltd.（Japan）
• Lonza Group AG（Switzerland）
• Now Health Group Inc.（United States）
• ProCaps Group（Luxembourg）
• Super Spectrim（United States）
• Thermo Fisher Scientific Inc.（United States）
• Key Developments
• Sirio Pharma Co., Ltd.（China）
• Soft Gel Technologies, Inc.（United States）
• EuroCaps Ltd.（United Kingdom）
• Geltec Pvt. Ltd.（India）
• Captek Softgel International, Inc.（United States）
• Elnova Pharma（Canada）
• Best Formulations（United States）
• Pharmavite LLC（United States）
• Robinson Pharma, Inc.（United States）

结论和建议

Global Enteric Softgel Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.5 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The market for enteric softgel capsules, which feature gelatin-based coatings for semi-solid and liquid medications, is poised for significant growth, driven by increasing consumer awareness of preventive medicine benefits, a rising geriatric population, and the prevalence of chronic and nutrient deficiency diseases. As health consciousness grows, so does the acceptance of dietary supplements, further fueling demand. Notably, innovative non-gelatin variants catering to vegan consumers are emerging, utilizing starch and plant-based sources to enhance market appeal. Additionally, the expansion of e-commerce platforms and heightened R&D investments by major players aimed at improving capsule bioavailability are set to positively influence market dynamics. Chewable softgel options that require no water to consume are anticipated to boost market prospects in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteric Softgel Market Segments Analysis

Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteric Softgel Market

The global enteric softgel market is primarily driven by a surge in investments aimed at enhancing the bioavailability of these capsules. Notably, leading companies are ramping up production to satisfy the growing demand for health-focused nutritional supplements. For instance, Catalent Pharma Solutions, a prominent American player, recently announced plans to invest over USD 5 million in a new drug development center located in Somerset, New Jersey. This investment is expected to bolster the company's capabilities in capsule coating technology, thereby strengthening its position within the enteric softgel market. As advanced manufacturing techniques are developed and major players focus on improving efficiency, the market is set to witness increased productivity and reduced complexity in drug development processes.

Restraints in the Global Enteric Softgel Market

The global enteric softgel market faces significant challenges related to the stability and shelf-life of these capsules. Consumers often encounter issues when storing enteric softgels for more than six months, leading to concerns about their efficacy. Moreover, the inherent dynamic nature of these capsules complicates efforts for manufacturers to enhance both their shelf-life and chemical stability. As a result, this limitation can hinder widespread adoption and consumer confidence in enteric softgel products, posing a notable restraint on market growth and innovation. Addressing these stability issues will be crucial for advancing the market potential of enteric softgel capsules.

Market Trends of the Global Enteric Softgel Market

The Global Enteric Softgel market is experiencing a notable shift towards vegan alternatives, driven by the rising trend of veganism and growing consumer awareness regarding animal welfare and health impacts associated with traditional gelatin-based capsules. As more consumers adopt vegetarian and vegan lifestyles, demand for plant-based enteric softgel options is expected to increase significantly. This paradigm shift is compelling manufacturers to innovate and reformulate products, utilizing ingredients such as hydroxypropyl methylcellulose and other plant-derived substances. Market dynamics are thus evolving, with a focus on sustainability and health-conscious choices poised to define the future landscape of the enteric softgel industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Enteric Softgel Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Gelatin Softgel Capsules
• Vegetarian Softgel Capsules

Global Enteric Softgel Market Size by Raw Material & CAGR (2025-2032)

• Market Overview
• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones and Skin)
• Fish Bone Gelatin
• Cellulose Derivatives
• Starch Material

Global Enteric Softgel Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Supermarket and Hypermarket
• Pharmacy and Drug store
• Online Provider

Global Enteric Softgel Market Size by Application & CAGR (2025-2032)

• Market Overview
• Antacid and Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplements
• Vitamin and Dietary Supplements
• Other Therapeutic Applications

Global Enteric Softgel Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Food Industry

Global Enteric Softgel Market Size & CAGR (2025-2032)

• North America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • US
  • Canada
• Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Capsule Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Now Health Group Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProCaps Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Super Spectrim (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Sirio Pharma Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soft Gel Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuroCaps Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geltec Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Captek Softgel International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elnova Pharma (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Formulations (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmavite LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robinson Pharma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations